Showing results (281-290 of 314) with videos related to
Sort By:
Pageof 32
Ophthalmology Science|October 17, 2022
Quantitative Parameters from OCT Angiography in Patients with Diabetic Retinopathy and in Those with Only Peripheral Retinopathy Compared with Control ParticipantsRuth E Hogg, David M Wright, Rosa Dolz-Marco, et al.BMJ Open|May 31, 2024
Study protocol: optical coherence tomography angiography for the detection of neovascular age-related macular degeneration: a comprehensive multicentre diagnostic accuracy study in the UK-the ATHENA studyMagdalena Niestrata, Jonathan J Deeks, Yemisi Takwoingi, et al.Experimental Eye Research|February 21, 2025
Dissecting the biological complexity of age-related macular degeneration: Is it one disease, multiple separate diseases, or a spectrum?Jason M L Miller, Benjamin R Thompson, James T Handa, et al.International Journal of Retina and Vitreous|August 27, 2020
The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degenerationEmily S Levine, Eugenia Custo Greig, Luísa S M Mendonça, et al.The British Journal of Ophthalmology|February 15, 2015
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12Aaron Y Lee, Cecilia S Lee, Thomas Butt, et al.Ophthalmology Science|February 2, 2024
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical PracticeRobyn Guymer, Clare Bailey, Voraporn Chaikitmongkol, et al.The British Journal of Ophthalmology|December 15, 2016
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedemaCatherine Egan, Haogang Zhu, Aaron Lee, et al.American Journal of Ophthalmology|June 3, 2017
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic RetinopathyCecilia S Lee, Aaron Y Lee, Douglas Baughman, et al.Ophthalmology. Retina|April 18, 2021
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2Kelvin Yi Chong Teo, Srinivas R Sadda, Chui Ming Gemmy Cheung, et al.Investigative Ophthalmology & Visual Science|May 10, 2014
FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expressionLeah A Owen, Margaux A Morrison, Jeeyun Ahn, et al.Pageof 32